{
    "clinical_study": {
        "@rank": "65642", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "100 cc of normal saline administered intravenously 10-30 minutes prior to anesthesia induction on the day of surgery."
            }, 
            {
                "arm_group_label": "IV Acetaminophen", 
                "arm_group_type": "Experimental", 
                "description": "100 cc of Acetaminophen (1000mg/100mL) administered intravenously 10-30 minutes prior to anesthesia induction on the day of surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether preoperative IV Acetaminophen reduces\n      postoperative pain and narcotic consumption in women undergoing surgical repair of pelvic\n      organ prolapse."
        }, 
        "brief_title": "IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair", 
        "condition": "Pelvic Organ Prolapse", 
        "condition_browse": {
            "mesh_term": [
                "Pain, Postoperative", 
                "Prolapse", 
                "Pelvic Organ Prolapse"
            ]
        }, 
        "detailed_description": {
            "textblock": "This randomized controlled trial of IV Acetaminophen compared to placebo will evaluate the\n      effect of preoperative IV Acetaminophen on postoperative pain scores and narcotic\n      requirements in women undergoing surgical repair of pelvic organ prolapse.  204 women will\n      randomly receive 1000 mg of IV Acetaminophen or saline preoperatively within 30 minutes of\n      surgical incision.  Subjects will be offered narcotic and non-narcotic pain medications as\n      needed during the postoperative period.  Visual analogue pain scales (VAS) will be obtained\n      at 4, 8, 12, 16, 20 and 24 hours postoperatively.  Narcotic consumption will be recorded in\n      morphine-equivalents.  We hypothesize that women receiving IV Acetaminophen will have lower\n      VAS scores and decreased narcotic requirements compared to controls."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women \u2265 18 years of age\n\n          -  scheduled to undergo surgery for POP via a vaginal or minimally invasive\n             (laparoscopic/robotic) route at the University of Pittsburgh Medical Center\n\n          -  women anticipated to have a hospital stay \u226524 hours\n\n        Exclusion Criteria:\n\n          -  allergy/intolerance to acetaminophen\n\n          -  hepatic dysfunction\n\n          -  significant alcohol use - defined as patient reported consumption of more than 7\n             standard drinks per week and/or 3 drinks per day"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "204", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02155738", 
            "org_study_id": "PFD-C-14-009"
        }, 
        "intervention": [
            {
                "arm_group_label": "IV Acetaminophen", 
                "intervention_name": "IV Acetaminophen", 
                "intervention_type": "Drug", 
                "other_name": "Ofirmev"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "IV normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "IV acetaminophen", 
            "Postoperative pain", 
            "Pelvic organ prolapse surgery", 
            "Pelvic organ prolapse repair"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Pittsburgh", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "15213"
                }, 
                "name": "Magee-Womens Hospital of the University of Pittsburgh Medical Center"
            }, 
            "investigator": {
                "last_name": "Lindsay Turner, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Impact of IV Acetaminophen on Postoperative Pain in Women Undergoing Pelvic Organ Prolapse Repair: A Double-Blind Randomized Placebo Controlled Trial", 
        "overall_contact": {
            "last_name": "Lindsay Turner, MD", 
            "phone": "4126411440"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Post operative pain will be assessed at baseline, 4, 8, 12, 16, 20 and 24 hours after surgery. Pain will be self reported by VAS pain scales which range from 0-100mm.", 
                "measure": "Change from Baseline in Postoperative Pain", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Equianalgesic dosage tables will be used to convert intra- and postoperative narcotics into morphine equivalents to compare narcotic requirements for the first week after surgery.", 
                "measure": "Narcotic consumption", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02155738"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To determine the impact of pain control on satisfaction and mood, subjects will be asked to complete the American Pain Society Patient Outcome Questionnaire (APS-POQ-R) on postoperative day (POD) #1.", 
                "measure": "Patient satisfaction and mood", 
                "safety_issue": "No", 
                "time_frame": "24 hours"
            }, 
            {
                "description": "Interference of pain with physical, mental and social activities will be measured by the Patient Reported Outcomes Measures Information Systems-Pain Interference-Short Form 8a (PROMIS PI-SF-8a) administered on POD#7.", 
                "measure": "Interference of pain with physical, mental and social activities", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }, 
            {
                "description": "Postoperative nausea, pruritus, dizziness and drowsiness will be assessed using the APS-POQ-R questionnaire administered on POD#1.  Constipation and time to first bowel movement will be measured with postoperative bowel diaries and the Bristol Stool Scale.", 
                "measure": "Side effects", 
                "safety_issue": "No", 
                "time_frame": "1 week"
            }
        ], 
        "source": "University of Pittsburgh", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Pittsburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}